Peking University Shenzhen Hospital — Shenzhen, Guangdong

Public research footprint of Peking University Shenzhen Hospital, compiled from the ClinicalTrials.gov public registry.

220

Registered studies

130

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Immunoglobulin A Nephropathy (IgAN) · Cervical Intraepithelial Neoplasia · Primary Membranous Nephropathy

Recently updated registry entries

NCT03429582 — Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device (Completed)
NCT03466411 — A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to… (Active Not Recruiting)
NCT04892173 — JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Peking University Shenzhen Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.